Eivind Hovig
Eivind Hovig
Professor.1. Centre for bioinformatics. Dept. of Informatics, Univ of Oslo. 2. Oslo Univ. Hosp.
Verified email at ifi.uio.no
Cited by
Cited by
Database of p53 gene somatic mutations in human tumors and cell lines.
M Hollstein, K Rice, MS Greenblatt, T Soussi, R Fuchs, T Sørlie, E Hovig, ...
Nucleic acids research 22 (17), 3551, 1994
A literature network of human genes for high-throughput analysis of gene expression
TK Jenssen, A Lægreid, J Komorowski, E Hovig
Nature genetics 28 (1), 21-28, 2001
Somatic Point Mutations in the p53 Gene of Human Tumors and Cell Lines: Updated Compilation
M Hollstein, B Shomer, M Greenblatt, T Soussi, E Hovig, R Montesano, ...
Nucleic acids research 24 (1), 141-146, 1996
Ten simple rules for reproducible computational research
GK Sandve, A Nekrutenko, J Taylor, E Hovig
PLoS computational biology 9 (10), e1003285, 2013
A uniform system for the annotation of vertebrate microRNA genes and the evolution of the human microRNAome
B Fromm, T Billipp, LE Peck, M Johansen, JE Tarver, BL King, ...
Annual review of genetics 49, 213-242, 2015
Database of p53 gene somatic mutations in human tumors and cell lines: updated compilation and future prospects
P Hainaut, T Soussi, B Shomer, M Hollstein, M Greenblatt, E Hovig, ...
Nucleic acids research 25 (1), 151-157, 1997
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database
P Møller, T Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ...
Gut 66 (3), 464-472, 2017
Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database
P Møller, TT Seppälä, I Bernstein, E Holinski-Feder, P Sala, DG Evans, ...
Gut 67 (7), 1306-1316, 2018
Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutations
AL Børresen, E Hovig, B Smith-Sørensen, D Malkin, S Lystad, ...
Proceedings of the National Academy of Sciences 88 (19), 8405-8409, 1991
A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing
TS Alioto, I Buchhalter, S Derdak, B Hutter, MD Eldridge, E Hovig, ...
Nature communications 6 (1), 1-13, 2015
Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma
GM Maelandsmo, VA Flørenes, T Mellingsaeter, E Hovig, RS Kerbel, ...
International journal of cancer 74 (4), 464-469, 1997
Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase‐polymerase chain reaction assays used to detect micrometastatic tumor cells
P Ruud, Ø Fodstad, E Hovig
International journal of cancer 80 (1), 119-125, 1999
Screening for germ line TP53 mutations in breast cancer patients
AL Børresen, TI Andersen, J Garber, N Barbier-Piraux, S Thorlacius, ...
Cancer research 52 (11), 3234-3236, 1992
S100A4 involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti …
K Bjørnland, JO Winberg, OT Ødegaard, E Hovig, T Loennechen, ...
Cancer research 59 (18), 4702-4708, 1999
TP53 mutations and breast cancer prognosis: Particularly poor survival rates for cases with mutations in the zinc‐binding domains
AL Børresen, TI Andersen, JE Eyfjörd, RS Cornelis, S Thorlacius, Å Borg, ...
Genes, Chromosomes and Cancer 14 (1), 71-75, 1995
A sequence-oriented comparison of gene expression measurements across different hybridization-based technologies
WP Kuo, F Liu, J Trimarchi, C Punzo, M Lombardi, J Sarang, ME Whipple, ...
Nature biotechnology 24 (7), 832-840, 2006
Methods that remove batch effects while retaining group differences may lead to exaggerated confidence in downstream analyses
V Nygaard, EA Rødland, E Hovig
Biostatistics 17 (1), 29-39, 2016
Performance comparison of four exome capture systems for deep sequencing
CSR Chilamakuri, S Lorenz, MA Madoui, D Vodák, J Sun, E Hovig, ...
BMC genomics 15 (1), 1-14, 2014
p53 abnormalities in different subtypes of human sarcomas
Å Andreassen, T Øyjord, E Hovig, R Holm, VA Flørenes, JM Nesland, ...
Cancer research 53 (3), 468-471, 1993
Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme
GM Mælandsmo, E Hovig, M Skrede, O Engebraaten, VA Flørenes, ...
Cancer research 56 (23), 5490-5498, 1996
The system can't perform the operation now. Try again later.
Articles 1–20